INDSWFTLTDPharmaceuticals & Biotechnology
Ind Swift — Profit & Loss Statement
₹15.76
+0.00%
Ind Swift Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 4.78 Cr | 0.60 Cr | 0.00 | -0.17 Cr | — |
| Tax Rate For Calcs | 0.02 | 0.14 | 0.00 | 0.30 | — |
| Normalized EBITDA | 41.87 Cr | 102.10 Cr | 52.22 Cr | 68.95 Cr | — |
| Total Unusual Items | 308.69 Cr | 4.41 Cr | 60.81 Cr | -0.55 Cr | — |
| Total Unusual Items Excluding Goodwill | 308.69 Cr | 4.41 Cr | 60.81 Cr | -0.55 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Reconciled Depreciation | 23.50 Cr | 27.11 Cr | 28.67 Cr | 32.07 Cr | — |
| Reconciled Cost Of Revenue | 260.18 Cr | 267.19 Cr | 241.89 Cr | 236.09 Cr | — |
| EBITDA | 350.57 Cr | 106.51 Cr | 113.03 Cr | 68.40 Cr | — |
| EBIT | 327.06 Cr | 79.40 Cr | 84.36 Cr | 36.32 Cr | — |
| Net Interest Income | -39.16 Cr | -62.94 Cr | -58.99 Cr | -56.09 Cr | — |
| Interest Expense | 39.16 Cr | 62.94 Cr | 58.32 Cr | 55.93 Cr | — |
| Normalized Income | -20.46 Cr | 10.42 Cr | -34.78 Cr | -19.63 Cr | — |
| Net Income From Continuing And Discontinued Operation | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Total Expenses | 515.75 Cr | 480.50 Cr | 382.70 Cr | 360.24 Cr | — |
| Diluted Average Shares | 5.42 Cr | 5.41 Cr | 5.42 Cr | 5.42 Cr | — |
| Basic Average Shares | 5.42 Cr | 5.41 Cr | 5.42 Cr | 5.42 Cr | — |
| Diluted EPS | 52.33 | 2.63 | 4.81 | -3.70 | — |
| Basic EPS | 52.33 | 2.63 | 4.81 | -3.70 | — |
| Diluted NI Availto Com Stockholders | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Net Income Common Stockholders | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Net Income Including Noncontrolling Interests | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 283.45 Cr | 14.23 Cr | 26.04 Cr | -20.02 Cr | — |
| Tax Provision | 4.46 Cr | 2.23 Cr | 0.00 | 0.42 Cr | — |
| Pretax Income | 287.91 Cr | 16.46 Cr | 26.04 Cr | -19.60 Cr | — |
| Other Non Operating Income Expenses | 18.89 Cr | 53.25 Cr | 2.71 Cr | 2.03 Cr | — |
| Special Income Charges | 308.69 Cr | 4.41 Cr | 60.81 Cr | -0.55 Cr | — |
| Other Special Charges | -308.69 Cr | 5.08 Cr | -60.82 Cr | -0.76 Cr | — |
| Net Non Operating Interest Income Expense | -39.16 Cr | -62.94 Cr | -58.99 Cr | -56.09 Cr | — |
| Interest Expense Non Operating | 39.16 Cr | 62.94 Cr | 58.32 Cr | 55.93 Cr | — |
| Operating Income | -0.52 Cr | 21.74 Cr | 16.19 Cr | 31.06 Cr | — |
| Operating Expense | 255.57 Cr | 213.32 Cr | 140.81 Cr | 124.15 Cr | — |
| Other Operating Expenses | 140.26 Cr | 101.66 Cr | 0.18 Cr | -9.25 Cr | — |
| Depreciation And Amortization In Income Statement | 23.50 Cr | 27.11 Cr | 28.67 Cr | 32.07 Cr | — |
| Depreciation Income Statement | 23.50 Cr | 27.11 Cr | 28.67 Cr | 32.07 Cr | — |
| Gross Profit | 255.05 Cr | 235.06 Cr | 157.00 Cr | 155.21 Cr | — |
| Cost Of Revenue | 260.18 Cr | 267.19 Cr | 241.89 Cr | 236.09 Cr | — |
| Total Revenue | 515.23 Cr | 502.25 Cr | 398.89 Cr | 391.30 Cr | — |
| Operating Revenue | 515.23 Cr | 502.25 Cr | 398.89 Cr | 391.30 Cr | — |
| Interest Income | — | 1.94 Cr | 0.77 Cr | 1.06 Cr | 1.81 Cr |
| Rent Expense Supplemental | — | 0.29 Cr | 0.34 Cr | 0.51 Cr | 0.45 Cr |
| Write Off | — | 0.34 Cr | 21000.00 | 1.31 Cr | 5.83 Cr |
| Total Other Finance Cost | — | 1.57 Cr | 1.44 Cr | 1.23 Cr | 0.73 Cr |
| Interest Income Non Operating | — | 1.94 Cr | 0.77 Cr | 1.06 Cr | 1.81 Cr |
| Research And Development | — | 9.79 Cr | 9.59 Cr | 5.24 Cr | 3.90 Cr |
| Selling General And Administration | — | 50.60 Cr | 45.13 Cr | 42.89 Cr | 37.05 Cr |
| Selling And Marketing Expense | — | 29.54 Cr | 28.15 Cr | 30.59 Cr | 27.30 Cr |
| General And Administrative Expense | — | 21.06 Cr | 16.97 Cr | 12.29 Cr | 9.75 Cr |
| Rent And Landing Fees | — | 0.29 Cr | 0.34 Cr | 0.51 Cr | 0.45 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ind Swift
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.